Alan Knuckman of Bulls-Eye Option spoke on Bloomberg Markets about a bullish
options strategy in Valeant Pharmaceuticals Intl Inc (NYSE: VRX).
He wants to sell the February 13 put in Valeant Pharmaceuticals for $0.65. The
trade breaks even at $12.35 or approximately 9 percent below the current market price. Knuckman explained that he's using a cash
secured naked put as a way to get in the stock at a lower price level or to get paid not to enter the position.
Knuckman added that the trade offers a chance to get in Valeant Pharmaceuticals
at a price level not seen since 2008.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.